[{"Assets_0_Q2_USD":2124900000.0,"CommonStockSharesOutstanding_0_Q2_shares":46791748.0,"EarningsPerShareBasic_1_Q2_USD":0.37,"EarningsPerShareBasic_2_Q2_USD":0.64,"EarningsPerShareDiluted_1_Q2_USD":0.36,"EarningsPerShareDiluted_2_Q2_USD":0.63,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":56700000.0,"NetIncomeLoss_1_Q2_USD":17100000.0,"NetIncomeLoss_2_Q2_USD":29900000.0,"StockholdersEquity_0_Q2_USD":1156800000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":47300000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":47300000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":46700000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":46700000.0,"Ticker":"AVNS","CIK":"1606498","name":"HALYARD HEALTH, INC.","OfficialName":"Avanos Medical Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1515595188.0","Country":"United States","Sector":"Health Care","Industry":"Industrial Specialties","Market":"NYSE","SP500":"nan","filed":"20170802"}]